Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...

Nader Yaghoubi, M.D., Ph.D., PathMaker's Co-Founder and CEO, stated, "We are pleased to announce IRB approval for the CALM study ... MyoRegulator® has been previously designated by the US Food and ...

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics is inadequate.

US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) for a Phase II trial of Arakoda (tafenoquine) for treating chronic ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase ... approved by the United States Food and Drug Administration for such an indication.

Investigational Review Board (IRB) approval has been granted for ... babesiosis and is not approved by the United States Food and Drug Administration for such an indication. Tafenoquine was ...

We welcome and support the U.S. Food and Drug Administration’s (FDA) proposal across the entire beauty industry.” US Reps. Shontel Brown of Ohio, Nydia Velázquez of New York and Ayanna ...